Edition:
United States

Accuray Inc (ARAY.O)

ARAY.O on Nasdaq

5.43USD
23 Feb 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.43
Open
$5.50
Day's High
$5.50
Day's Low
$5.30
Volume
657,844
Avg. Vol
633,068
52-wk High
$6.39
52-wk Low
$4.45

Latest Key Developments (Source: Significant Developments)

Accuray posts Q2 loss per share $0.11
Tuesday, 31 Jan 2017 04:01pm EST 

Accuray Inc : Q2 ending product backlog was $426.2 million, approximately 16 percent higher . Q2 loss per share $0.11 . Q2 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S . Qtrly total revenue was $87.5 million compared to $108.9 million in prior fiscal year Q2 . Reaffirming guidance originally provided on August 17, 2016 for fiscal year 2017 for all metrics except operating expenses . FY2017 earnings per share view $-0.19, revenue view $409.4 million -- Thomson Reuters I/B/E/S .Q2 revenue view $90.4 million -- Thomson Reuters I/B/E/S.  Full Article

Accuray reports Q4 loss per share $0.09
Wednesday, 17 Aug 2016 04:01pm EDT 

Accuray Inc : Accuray reports fourth quarter and fiscal 2016 financial results . Q4 loss per share $0.09 . Q4 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S . Q4 revenue $95 million versus i/b/e/s view $99 million . Sees FY 2017 revenue $410 million to $420 million . Backlog increased 8 percent year-over-year to $405.9 million in quarter . Sees fy 2017 adjusted ebitda $32.0 million to $38.0 million . FY2017 revenue view $431.8 million -- Thomson Reuters I/B/E/S . Qtrly gross orders increased 12 percent over prior year period to $95.4 million . Sees FY 2017 backlog and gross orders growth of approximately 5 percent .Approximately 55 percent of revenue and 60 percent of gross orders are anticipated in second half of fiscal year in fy 2017.  Full Article

Accuray CE marks its radixact system
Tuesday, 9 Aug 2016 06:30am EDT 

Accuray Inc : CE marked its radixact treatment delivery system, Accuray precision treatment planning system and IDMS data management system . Platform will now be available in certain markets in European Union (EU) .Have shipped first commercially released radixact system to a site in U.S. and expect first eu shipment during fiscal Q1 2017.  Full Article

Accuray retires remaining 3.75 percent convertible debt
Tuesday, 2 Aug 2016 06:30am EDT 

Accuray Inc : Retires remaining 3.75 percent convertible debt . Says 2016 notes were settled on August 1 for $37.3 million, which included $36.6 million in principal and $0.7 million in accrued interest .Says settled remaining principal amount and accrued interest thereon of 3.75 percent convertible senior notes.  Full Article

Accuray receives 510(K) FDA clearance for image-guided radiation therapy
Monday, 27 Jun 2016 06:30am EDT 

Accuray: Accuray receives 510(k) FDA clearance for the Radixact image-guided radiation therapy platform and integrated software .Will initiate commercial release of Radixact system late in Q1 of fiscal year 2017.  Full Article

Accuray sees FY 2016 backlog about $405 mln
Tuesday, 24 May 2016 04:23pm EDT 

Accuray Inc :Accuray Inc sees FY 2016 backlog about $405 million - SEC filing.  Full Article

Accuray Inc Reaffirms FY 2016 guidance
Thursday, 28 Jan 2016 04:03pm EST 

Accuray Inc:Reaffirmed previously provided financial guidance For Fy 2016.Says Fy 2016 Total revenue is expected to be between $395 million to $410 million and adjusted EBITDA is expected to range between $25 million to $35 million.Accuray continues to expect Fy 2016 gross orders for Fy 2016 will be approximately $295 million, which would represent a 10 percent increase year over year.  Full Article

Accuray Inc announces repurchases of convertible debt
Tuesday, 19 Jan 2016 06:00am EST 

Accuray Inc:Announces repurchases of convertible debt.Repurchased about $63.4 million in principal amount of 3.75% convertible senior notes due August 2016 for $66.6 million in cash.  Full Article

Accuray Inc closes $70 million straight debt financing
Tuesday, 12 Jan 2016 06:30am EST 

Accuray Inc:Closes $70 million straight debt financing.Says net proceeds of loan to be used, in addition to $30 million of cash funded by Accuray, to retire $100 million of convertible notes.  Full Article

Accuray Inc Reaffirms FY 2016 guidance
Thursday, 29 Oct 2015 04:01pm EDT 

Accuray Inc:Reaffirms its financial guidance for FY 2016 on total revenue of $395 million to $410 million and adjusted EBITDA of $25 million to $35 million.FY 2016 revenue of $402 million - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Accuray posts Q2 loss per share $0.11

* Q2 ending product backlog was $426.2 million, approximately 16 percent higher